Taitel Haya's Form 4 filing
Entera Bio Ltd. (ENTX) · filed Jan 16, 2024
- Accession no.
- 0001178913-24-000164
- Filed
- Jan 16, 2024
- Trade date
- Jan 12, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $9.40K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Taitel HayaCIK 0001979599 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Ordinary Shares, par value NIS 0.0000769 per share | PPurchaseAcquired | +9,500 | $0.99 | +$9,405 | 35,115 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.